Market Cap 1.75B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 9,324,700
Avg Vol 6,431,942
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 97%
Beta 1.02
Analysts Strong Sell
Price Target $10.43

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
wgilus69
wgilus69 May. 30 at 3:49 AM
$ABCL nice! higher
0 · Reply
N2Deeeep
N2Deeeep May. 30 at 3:11 AM
$ABCL Long time coming with this one
0 · Reply
SultanK
SultanK May. 30 at 1:21 AM
$ABCL With volume going up, short ratio is now down to may be 5 days.. Interesting..
0 · Reply
UncleTomFlorida
UncleTomFlorida May. 29 at 9:13 PM
$ABCL Reached well over critical mass for $ABCL today. It’s now sufficiently established to become self sustaining. Of course, the markets being the markets the stock could go south again. But given no negative change to the fundamentals, there is no need to do anything other than lean back and enjoy the show.
2 · Reply
Quadruple_Double
Quadruple_Double May. 29 at 8:03 PM
$ABCL see you on Monday. Enjoy your weekend folks !
0 · Reply
Reactor_Rebel
Reactor_Rebel May. 29 at 8:01 PM
$ABCL monday we fly
0 · Reply
freedomtrader6
freedomtrader6 May. 29 at 7:57 PM
$ABCL Crazy to think $ABCL spent most of the year sitting around $3 while almost nobody cared. At those levels, you literally could’ve bought 2 shares for the price of 1 today That’s why I keep saying the market often rewards people who focus on exceptional businesses instead of obsessing over whether a stock is “popular” at the moment. Most people only become interested AFTER the chart goes vertical The funny part about investing is that the best opportunities usually feel boring, ignored, or even uncomfortable before they become obvious to everyone else
3 · Reply
Odoji
Odoji May. 29 at 7:54 PM
$ABCL 💉
1 · Reply
freedomtrader6
freedomtrader6 May. 29 at 7:53 PM
$ABCL Crazy to think··· $ABCL spent most of the year sitting around $3 while almost nobody cared. At those levels, you literally could’ve bought 2 shares for the price of 1 today That’s why I keep saying the market often rewards people who focus on exceptional businesses instead of obsessing over whether a stock is “popular” at the moment. Most people only become interested AFTER the chart goes vertical The funny part about investing is that the best opportunities usually feel boring, ignored, or even uncomfortable before they become obvious to everyone else
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 29 at 7:20 PM
$ABCL God, Bless the shorts with patience as they refresh their screens, waiting for the drop that only rises higher. Let them embrace the green tide, whether they like it or not. Amen 🙏🌊📈 $ABCL
0 · Reply
Latest News on ABCL
AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 17 days ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Q1 Earnings Call Highlights

May 11, 2026, 7:08 PM EDT - 18 days ago

AbCellera Biologics Q1 Earnings Call Highlights


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 18 days ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 18 days ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 18 days ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 18 days ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 24 days ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 weeks ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 weeks ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 7 weeks ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 3 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 3 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 4 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 7 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 7 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 9 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 9 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera doses first participants in Phase 1 trial of ABCL575

2025-08-27T13:20:26.000Z - 9 months ago

AbCellera doses first participants in Phase 1 trial of ABCL575


AbCellera price target raised to $7 from $5 at BMO Capital

2025-08-08T13:26:29.000Z - 10 months ago

AbCellera price target raised to $7 from $5 at BMO Capital


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 10 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera assumed with an Outperform at Leerink

2025-07-07T10:40:33.000Z - 11 months ago

AbCellera assumed with an Outperform at Leerink


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


wgilus69
wgilus69 May. 30 at 3:49 AM
$ABCL nice! higher
0 · Reply
N2Deeeep
N2Deeeep May. 30 at 3:11 AM
$ABCL Long time coming with this one
0 · Reply
SultanK
SultanK May. 30 at 1:21 AM
$ABCL With volume going up, short ratio is now down to may be 5 days.. Interesting..
0 · Reply
UncleTomFlorida
UncleTomFlorida May. 29 at 9:13 PM
$ABCL Reached well over critical mass for $ABCL today. It’s now sufficiently established to become self sustaining. Of course, the markets being the markets the stock could go south again. But given no negative change to the fundamentals, there is no need to do anything other than lean back and enjoy the show.
2 · Reply
Quadruple_Double
Quadruple_Double May. 29 at 8:03 PM
$ABCL see you on Monday. Enjoy your weekend folks !
0 · Reply
Reactor_Rebel
Reactor_Rebel May. 29 at 8:01 PM
$ABCL monday we fly
0 · Reply
freedomtrader6
freedomtrader6 May. 29 at 7:57 PM
$ABCL Crazy to think $ABCL spent most of the year sitting around $3 while almost nobody cared. At those levels, you literally could’ve bought 2 shares for the price of 1 today That’s why I keep saying the market often rewards people who focus on exceptional businesses instead of obsessing over whether a stock is “popular” at the moment. Most people only become interested AFTER the chart goes vertical The funny part about investing is that the best opportunities usually feel boring, ignored, or even uncomfortable before they become obvious to everyone else
3 · Reply
Odoji
Odoji May. 29 at 7:54 PM
$ABCL 💉
1 · Reply
freedomtrader6
freedomtrader6 May. 29 at 7:53 PM
$ABCL Crazy to think··· $ABCL spent most of the year sitting around $3 while almost nobody cared. At those levels, you literally could’ve bought 2 shares for the price of 1 today That’s why I keep saying the market often rewards people who focus on exceptional businesses instead of obsessing over whether a stock is “popular” at the moment. Most people only become interested AFTER the chart goes vertical The funny part about investing is that the best opportunities usually feel boring, ignored, or even uncomfortable before they become obvious to everyone else
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 29 at 7:20 PM
$ABCL God, Bless the shorts with patience as they refresh their screens, waiting for the drop that only rises higher. Let them embrace the green tide, whether they like it or not. Amen 🙏🌊📈 $ABCL
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 29 at 7:18 PM
$ABCL I wouldn’t want to go into this weekend without any $ABCL shares 👀😉 I actually added more. Next week will be fun
0 · Reply
tranq19
tranq19 May. 29 at 7:09 PM
$ABCL look at the chart and volume today, big run up to 6.23 on big volume buys, drifting lower on low volume
0 · Reply
DeMampCamp
DeMampCamp May. 29 at 7:06 PM
$ABCL Welcome back to the board, dummy, you finally sell for a loss and now coming back to show your ignorance once again?
1 · Reply
Stocktradesmoon
Stocktradesmoon May. 29 at 7:05 PM
$ABCL I just bought more shares possible news heading into next week June 4th Jeffries conference
1 · Reply
DeMampCamp
DeMampCamp May. 29 at 7:03 PM
$ABCL Going to be an all out battle to keep this above $6 going into close, a ton of short term (fake longs) traders are going to take their profits not wanting to hold into the weekend!
1 · Reply
Bgggggggie
Bgggggggie May. 29 at 6:45 PM
$ABCL lol, this isnt worth more than a buck, super high cash burn and nothing to show for it
1 · Reply
BillionaireMotion
BillionaireMotion May. 29 at 6:00 PM
$ABCL $CLOV $RVSN $INTC Trump will buy these
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 29 at 5:43 PM
$ABCL Investment thesis. Peter Lynch said, you should be able to explain your investment ideas using crayons to 7 year old. So here goes my one page investment thesis on AbCellera !
1 · Reply
Plutten1973
Plutten1973 May. 29 at 5:33 PM
$ABCL Amazing ! maybe finnally
0 · Reply
Odoji
Odoji May. 29 at 5:27 PM
$ABCL 💉
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 29 at 5:27 PM
$ABCL Abcellera is close to its moment. biotech is next Next stop $15 $ABCL 🚀
1 · Reply
Stocktradesmoon
Stocktradesmoon May. 29 at 5:22 PM
$ABCL we like vertical accumulation 👀😉
0 · Reply